| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/28/2002 | EP1234174A1 Protein-protein interactions |
| 08/28/2002 | EP1234040A2 Hbv sequences |
| 08/28/2002 | EP1234039A2 85kDa NEISSERIAL ANTIGEN |
| 08/28/2002 | EP1234037A2 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE |
| 08/28/2002 | EP1234036A2 Compositions and methods for the treatment of immune related diseases |
| 08/28/2002 | EP1234035A1 Human cytokine receptor |
| 08/28/2002 | EP1234030A2 18 human secreted proteins |
| 08/28/2002 | EP1234027A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1234025A1 Human enzymes of the metalloprotease family |
| 08/28/2002 | EP1233987A1 Immobilized single domain antigen-binding molecules |
| 08/28/2002 | EP1233983A2 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1233982A2 Novel hcv non-structural polypeptide |
| 08/28/2002 | EP1233981A1 G-protein coupled receptor |
| 08/28/2002 | EP1233980A2 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 08/28/2002 | EP1233979A1 Method of diagnosing neurodegenerative disease |
| 08/28/2002 | EP1233978A1 Compositions and methods for the improved diagnosis and treatment of germ cell tumors |
| 08/28/2002 | EP1233975A1 29 human secreted proteins |
| 08/28/2002 | EP1233974A2 37 staphylococcus aureus genes and polypeptides |
| 08/28/2002 | EP1233790A2 A33 antigen specific immunoglobulin products in cancer therapy |
| 08/28/2002 | EP1233785A1 "bonzo" chemokine receptor antibodies and ligands |
| 08/28/2002 | EP1233781A1 Assays and therapies for latent viral infection |
| 08/28/2002 | EP1233780A1 Identification of sortase gene |
| 08/28/2002 | EP1233779A2 New uses of suppressive macrophage activation factors |
| 08/28/2002 | EP1233778A1 Stanniocalcin proteins and nucleic acids and methods based thereon |
| 08/28/2002 | EP1233777A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1187845A4 Tumor suppressor molecules and methods of use |
| 08/28/2002 | EP1141270A4 Ethylene-response-factor1 (erf1) in plants |
| 08/28/2002 | EP0988063B1 Process for reducing the concentration of viral and molecular pathogens in a biological material |
| 08/28/2002 | EP0942978B1 Methods for producing the anaphase promoting complex |
| 08/28/2002 | EP0928201B1 Novel glycolipid complexes and their uses |
| 08/28/2002 | EP0877626B1 Anti-cd18 antibodies for use against stroke |
| 08/28/2002 | EP0827591B1 Method for diagnosing chlamydia using an extracellular biological fluid |
| 08/28/2002 | EP0822828B1 Isolated 55 to 75 kda protein which binds to prion protein |
| 08/28/2002 | EP0808173B1 Product and method for preventing respiratory virus infection |
| 08/28/2002 | EP0804489B1 Antigenic preparation for treatment or prevention of helicobacter infection |
| 08/28/2002 | EP0794966B1 Humanized antibodies to cd38 |
| 08/28/2002 | CN1366049A Chinese bee venom AcHA gene, polypeptide coded by it and its preparing process |
| 08/28/2002 | CN1366046A Coding sequence, preparing process and application of human disease associated epidermal growth factor |
| 08/28/2002 | CN1366044A Preparing process and application of lysozyme protein |
| 08/28/2002 | CN1089802C Monoclone antibody cell strain and its monoclone antibody with hepatitis C virus resisting non-structure zone 4 antigen |
| 08/28/2002 | CN1089609C Method of recovering immunoglobulin from fractions produced during fractionation of human blood plasma |
| 08/28/2002 | CN1089607C Immunomodulatory complex for helicobacter bacteria |
| 08/28/2002 | CN1089606C Conjugate between modified superantigen and target-seeking compound and use of conjugate |
| 08/27/2002 | US6441147 Batch commercial scale isolation of concentrated, active natural or recombinant proteins from intercellular material via vacuum and centrifugation; nondestructive to plants; pharmaceutical quality enzymes, cytokines and antibodies |
| 08/27/2002 | US6441144 Method for repairing dual virally inactivated immune globulin for intravenous administration |
| 08/27/2002 | US6441143 Identifying cancer patients with greatest probability of relapse; monoclonal antibody which binds to denatured epitope comprising a subset of amino acid residues 96-191; stomach, breast, lung, pancreatic, prostate or ovarian tumors |
| 08/27/2002 | US6441142 Detecting and quantifying allergens in foods; monoclonal antibody having antigen combining site with specificity for amino acid sequence arachis hypogaea ii; hybridoma cell lines which produce the antibodies |
| 08/27/2002 | US6441141 Synthetic peptides, antibodies against them and their use |
| 08/27/2002 | US6441140 Production of motif-specific and context-independent antibodies using peptide libraries as antigens |
| 08/27/2002 | US6441139 Agents and method for identifying insects |
| 08/27/2002 | US6441137 Tie-2 ligands; tie= ?tyrosine kinase with ig (immunoglobulins) and egf (epidermal growth factor) homology domains?; tumor neovascularization |
| 08/27/2002 | US6441133 Thyrotropin-releasing hormone receptor 2(TRHR-2) |
| 08/27/2002 | US6440944 Methods of administering adenoviral vectors |
| 08/27/2002 | US6440736 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules |
| 08/27/2002 | US6440733 Monoclonal antibodies recognizing antigens on the surface of endothelial cells of tumor vessel |
| 08/27/2002 | US6440732 Checkpoint/repair genes involved with dna repair prior to replication; aging resistance; cancer therapy |
| 08/27/2002 | US6440699 Prostate cancer susceptible CA7 CG04 gene |
| 08/27/2002 | US6440694 Which is a tumor necrosis factor (tnf) homolog of given nucleotide sequence and amino acid sequence |
| 08/27/2002 | US6440680 Using dna encoding the novel prostaglandin receptor and host cells expressing the receptor |
| 08/27/2002 | US6440418 Variable light and heavy amino acid sequences encoded by nucleic acid sequences; seq id no:24, 25 and 26; rheumatoid arthritis, multiple sclerosis, diabetes, and systemic lupus erythematosus; graft versus host disease; gene therapy |
| 08/27/2002 | US6440417 Measuring concentration of therapeutic agent in blood or serum with high specificity; isolated monoclonal antibody produced by hybridoma cell line 9c10 having atcc accession number pta-3772 |
| 08/27/2002 | US6440416 Primate antiidiotype antibody or fragment acting as immuno-genic functional mimic; preventive or therapeutic immune response against tumors, viruses, bacteria, rickettsia, mycoplasma, protozoa, fungi and multicellular parasites |
| 08/27/2002 | US6440386 Stabilized radiophosphate-labeled proteins |
| 08/27/2002 | CA2069929C Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins |
| 08/27/2002 | CA2018592C Polypeptides and polypeptide analogues with inhibitory activity against human elastase |
| 08/22/2002 | WO2002065126A2 Use of troponin i as a species marker protein for meat speciation in both raw and heat-processed products |
| 08/22/2002 | WO2002064827A2 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof |
| 08/22/2002 | WO2002064795A2 Putative human enzymes |
| 08/22/2002 | WO2002064792A2 Molecules for disease detection and treatment |
| 08/22/2002 | WO2002064791A2 Proteins and nucleic acids encoding same |
| 08/22/2002 | WO2002064788A2 Compositions and methods relating to lung specific genes and proteins |
| 08/22/2002 | WO2002064787A1 Neurotonin and use thereof |
| 08/22/2002 | WO2002064785A1 NOVEL CLOCK GENE Bmal2 |
| 08/22/2002 | WO2002064771A1 Novel cell adhesion molecule specific to activated leukocyte |
| 08/22/2002 | WO2002064766A2 Bax-responsive genes for drug target identification in yeast and fungi |
| 08/22/2002 | WO2002064763A1 Novel human poly(a)polymerase gamma (pap gamma) |
| 08/22/2002 | WO2002064746A2 Combined transductional and transcriptional targeting system for improved gene delivery |
| 08/22/2002 | WO2002064742A2 Compounds effecting neuron remodeling and assays for same |
| 08/22/2002 | WO2002064731A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 08/22/2002 | WO2002064634A2 Human monoclonal antibodies to fc alpha receptor (cd89) |
| 08/22/2002 | WO2002064633A1 Monoclonal antibody against an unknown antigen from amniotic flu id and its method of preparation |
| 08/22/2002 | WO2002064631A2 T1r taste receptors and genes encoding same |
| 08/22/2002 | WO2002064629A2 Isolated human transporter proteins, nucleic acid molecules encoding them and uses thereof |
| 08/22/2002 | WO2002064626A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 08/22/2002 | WO2002064621A2 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent |
| 08/22/2002 | WO2002064615A2 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
| 08/22/2002 | WO2002064612A2 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 08/22/2002 | WO2002064161A2 Method and compositions for immunization with the pseudomonas v antigen |
| 08/22/2002 | WO2002064159A1 Remedies for tumor in hematopoietic organs |
| 08/22/2002 | WO2002064022A2 Therapy for cerebral vasospasm |
| 08/22/2002 | WO2002047534A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/22/2002 | WO2002010394A3 Nucleic acids, by means of which plants with altered metabolite content can be produced |
| 08/22/2002 | WO2002002773A3 Dual specificity antibodies and methods of making and using |
| 08/22/2002 | WO2001085204A3 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 08/22/2002 | WO2001085203A3 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 08/22/2002 | WO2001074903A3 Cd20/ige-receptor like molecules and uses thereof |
| 08/22/2002 | WO2001072295A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/22/2002 | WO2000036092A9 METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-β RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION |
| 08/22/2002 | WO2000032239A9 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 08/22/2002 | WO2000026256A9 Modified antibodies and antibody fragments with increased duration of activity |